Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus (HIV)-positive and HIV-negative drug users

American Journal of Epidemiology

Volumn 143, Issue 4, 1996, Pages 380-391

  Van Haastrecht, H J A ^a   Van Ameijden, E J C ^a   Van Den Hoek, J A R ^a   Mientjes, G H C ^a   Bax, J S ^a   Coutinho, R A ^a  

^a MUNICIPAL HEALTH SERVICE   (Netherlands)

Author keywords

acquired immunodeficiency syndrome; benzodiazepines; cause of death; HIV infection; methadone; mortality; substance abuse, intravenous

Indexed keywords

AMPHETAMINE DERIVATIVE; BENZODIAZEPINE DERIVATIVE; COCAINE; DIAMORPHINE; METHADONE;

ADOLESCENT; ADULT; ARTICLE; CAUSE OF DEATH; DRUG ABUSE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NETHERLANDS; RISK ASSESSMENT; SERODIAGNOSIS;

EID: 0030062624     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a008752     Document Type: Article

References (32)

1. Perucci CA, Davoli M, Rapiti E, et al. Mortality of intravenous drug users in Rome: a cohort study. Am J Public Health 1991;81:1307-10.
2. Eskild A, Magnus P, Samuelsen SO, et al. Differences in mortality rates and causes of death between HIV positive and HIV negative intravenous drug users. Int J Epidemiol 1993; 22:315-19.
3. Stoneburner RL, Des Jarlais DC, Benezra D, et al. A larger spectrum of severe HIV-1-related disease in intravenous drug users in New York City. Science 1988;242:916-19.
4. Selwyn PA, Hartel D, Wasserman W, et al. Impact of the AIDS epidemic on morbidity and mortality among intravenous drug users in a New York City methadone maintenance program. Am J Public Health 1989;79:1358-62.
5. Zaccarelli M, Gattari P, Rezza G, et al. Impact of HIV infection on non-AIDS mortality among Italian injecting drug users. AIDS 1994;8:345-50.
6. van Haastrecht HJA, van den Hoek JAR, Coutinho RA. High mortality among HIV-infected injecting drug users without AIDS-diagnosis: implications for HIV-infection epidemic modelers? AIDS 1994;8:363-6.
7. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep 1987;36(suppl 1):1S-15S.
8. van den Hoek JAR, Coutinho RA, van Haastrecht HJA, et al. Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam. AIDS 1988; 2:55-60.
9. van Haastrecht HJA, van den Hoek JAR, Bardoux C, et al. The course of the HIV epidemic among intravenous drug users in Amsterdam, the Netherlands. Am J Public Health 1991;81: 59-62.
10. van Ameijden EJC, van den Hoek JAR, van Haastrecht HJA, et al. The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam. Am J Epidemiol 1992; 136:236-43.
11. Hartgers C, van den Hoek JAR, Krijnen P, et al. HIV prevalence and risk behavior among injecting drug users who participate in "low threshold" methadone programs in Amsterdam. Am J Public Health 1992;82:547-51.
12. Mientjes GHC, van Ameijden EJC, van den Hoek JAR, et al. Progression of HIV infection among injecting drug users: indications for a lower rate of progression among those who have frequently borrowed injecting equipment. AIDS 1993;7: 1363-70.
13. Hartgers C, van den Hoek JAR, Coutinho RA, et al. Psychopathology, stress, and HIV-risk injecting behaviour among drug users. Br J Addiction 1992;98:857-65.
14. Koot M, Vos AHV, Keet RPM, et al. HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS 1992;6:49-54.
15. Statistics and Epidemiology Research Corporation. EGRET reference manual, first draft, revision 3. Seattle: Statistics and Epidemiology Research Corporation, 1992.
16. Mientjes GHC, Miedema F, van den Hoek JAR, et al. Immunologic alterations in splenectomized HIV-infected intravenous drug users. AIDS 1994;8:269-71.
17. Selwyn PA, Alcabes P, Hartel D, et al. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med 1992; 327:1697-703.
18. van Brussel GHA, van Lieshout SJM. Drug department annual report 1990. (In Dutch). Amsterdam: Municipal Health Service, 1991.
19. Rothman KJ, Modem epidemiology. Boston: Little, Brown, 1986.
20. Eskild A, Magnus P, Sohlberg C, et al. Slow progression to AIDS in intravenous drug users infected with HIV in Norway. J Epidemiol Community Health 1994;48:383-7.
21. Ancelle RA. European AIDS definition. (Letter). Lancet 1992; 339:671.
22. Mientjes GH, van Ameijden EJ, van den Hoek JAR, et al. Increasing morbidity without rise in non-AIDS mortality among HIV-infected intravenous drug users in Amsterdam. AIDS 1992;6:207-12.
23. Starace F. Suicidal behaviour in people infected with human immunodeficiency virus: a literature review. Int J Soc Psychiatry 1993;39:64-70.
24. van Haastrecht HJA, Mientjes GHC, van den Hoek JAR, et al. Death from suicide and overdose among drug injectors after first HIV test result disclosure. AIDS 1994;8:1721-5.
25. van Ameijden EJC, van den Hoek JAR, Mientjes GHC, et al. A longitudinal study on the incidence and transmission patterns of HIV, HBV, and HCV infection among drug users in Amsterdam. Eur J Epidemiol 1993;9:255-62.
26. Spijkerman IJB, Koot M, Prins M, et al. Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users compared with homosexual men. AIDS 1995;9:1085-92.
27. Richman DD, Bozzette SA. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J Infect Dis 1994; 169:968-74.
28. Gronbladh L, Ohlund LS, Gunne LM. Mortality in heroin addiction: impact of methadone treatment. Acta Psychiatr Scand 1990;82:223-7.
29. Caplehorn JR, Dalton MS, Cluff MC, et al. Retention in methadone maintenance and heroin addicts' risk of death. Addiction 1994;89:203-9.
30. Marks J. Deaths from methadone and heroin. (Letter). Lancet 1994;343:976.
31. Darke S, Swift W, Hall W, et al. Drug use, HIV risk-taking, and psychosocial correlates of benzodiazepine use among methadone maintenance clients. Drug Alcohol Depend 1993; 34:67-70.
32. van Ameijden EJC, van den Hoek JAR, Coutinho RA. Injecting risk behavior among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs. Am J Public Health 1994;84:275-81.